SBAC

SBA Communications

$173.33

+2.16%
Nov 20, 2026
Bobby Quantitative Model
SBA Communications Corporation is a specialized real estate investment trust that owns and operates a portfolio of roughly 46,000 wireless communications towers across North America, South America, and Africa, leasing vertical space and related infrastructure to mobile network operators who install antennas and transmission equipment on its sites. The company is a pure-play tower landlord and one of the three dominant U.S. tower operators alongside American Tower and Crown Castle, distinguished by an unusually concentrated revenue base—its top three or four carriers generate the bulk of leasing revenue in each market—and a geographic mix in which more than 17,000 U.S. towers drive roughly 70% of leasing revenue while Brazil and Guatemala anchor the international book. The current investor debate centers on decelerating organic growth, with total revenue of $713.9 million in the September 2026 quarter declining 2.5% year over year, prompting questions about carrier capex discipline, Sprint-related churn anniversary dynamics, and the durability of the tower model's long-term lease escalators. Management's capital allocation—aggressive buybacks ($300 million repurchased in Q3 2026 alone), steady deleveraging, and a modest 2.3% dividend yield—frames the stock as a cash-flow and balance-sheet story rather than a growth story, and the shares have de-rated accordingly over the past year.

People also watch

Equinix

Equinix

EQIX

Analysis
American Tower Corporation

American Tower Corporation

AMT

Analysis
Digital Realty Trust

Digital Realty Trust

DLR

Analysis
Crown Castle International Corp.

Crown Castle International Corp.

CCI

Analysis
Iron Mountain Incorporated

Iron Mountain Incorporated

IRM

Analysis

BobbyInvestment Opinion: Should I buy SBAC Today?

Rating: Hold, with a constructive bias toward accumulating on weakness. The core thesis is that SBAC is a high-margin, contract-backed tower landlord generating $1.045 billion of trailing free cash flow and trading at a de-rated 19.68x trailing PE, but with revenue contracting 2.51% year over year and interest expense consuming 36% of operating income, the 28.2% implied upside to the $222.19 average analyst target is unlikely to be realized until domestic leasing growth inflects. The 11 Buy / 11 Hold / 0 Sell consensus (recommendation mean 2.18) captures this tension precisely: the Street sees value but is not yet willing to pay for it.

Supporting evidence is genuinely mixed. On the positive side, Q3 2026 gross margin of 75.97%, operating margin of 51.5%, and EBITDA margin of 66.0% confirm the durability of the tower model, while the 45.5% dividend payout ratio and 2.31% yield are comfortably covered by $252.3 million of quarterly free cash flow and coexist with $300 million of Q3 buybacks and $142.6 million of debt repayment. The trailing PE has compressed from 72.9x in Q4 2022 to 19.68x, and the PEG of 0.477 suggests the de-rating has overshot relative to earnings growth. Against that, PS of 7.37x and EV/EBITDA of 17.79x remain above the roughly 14-16x tower-REIT norm despite flat revenue, the forward PE of 21.88x exceeds the trailing 19.68x (implying expected earnings decline), and the current ratio of 0.49 leaves minimal liquidity cushion.

The biggest risks that would invalidate even a Hold are a further leg down in domestic site leasing from its $454.4 million plateau, a carrier capex freeze or consolidation event that removes a top-three tenant's tenancy, and a refinancing environment that pushes interest expense above its current 36% of operating income. This Hold would upgrade to Buy if domestic site leasing returns to positive year-over-year growth or if the stock retests the $156.60 52-week low while free cash flow holds above $1 billion; it would downgrade to Sell if revenue declines accelerate beyond -5% or if the dividend payout ratio exceeds 60%. On balance the stock looks fairly valued to modestly undervalued relative to its own history but expensive relative to peers on EBITDA—a value-with-a-catalyst-required situation rather than a clean bargain.

Sign up to view all

SBAC 12-Month Price Forecast

SBAC is a cash-flow story in search of a growth catalyst: $1.045 billion of TTM free cash flow and a 66.0% EBITDA margin are offset by a 2.51% revenue decline and interest expense eating 36% of operating income. The valuation is bifurcated—cheap on trailing earnings at 19.68x and a 0.477 PEG, but rich on EV/EBITDA at 17.79x versus the 14-16x peer norm—which explains the 11 Buy / 11 Hold split and the wide $165-$280 target range. The stock's recent relative strength (+9.66% versus SPY over one month) suggests selling pressure is decelerating above the $156.60 low, but without a domestic leasing inflection the 28.2% upside to the average target is unlikely to be realized within twelve months. I would upgrade to bullish on evidence of positive domestic site leasing growth or a decisive break above the $190-$195 resistance zone, and downgrade to bearish if revenue declines accelerate beyond -5% or the dividend payout ratio exceeds 60%.

Historical Price
Current Price $173.33
Average Target $197.76
High Target $280.00
Low Target $156.60

Wall Street consensus

Most Wall Street analysts maintain a constructive view on SBA Communications's 12-month outlook, with a consensus price target around $222.19 and implied upside of +28.2% versus the current price.

Average Target

$222.19

22 analysts

Implied Upside

+28.2%

vs. current price

Analyst Count

22

covering this stock

Price Range

$165 - $280

Analyst target range

Buy
11 (50%)
Hold
11 (50%)
Sell
0 (0%)

Coverage is broad and the consensus is moderately bullish. Twenty-one analysts cover SBAC, with a distribution of 11 Buy, 11 Hold, and 0 Sell ratings, yielding a consensus recommendation of "buy" and a recommendation mean of 2.18 (where lower is more bullish). The average target price of $222.19 implies roughly 28.2% upside from the current $173.33, a meaningful gap that suggests the sell-side views the recent decline as overdone. Consensus EPS estimates of $10.02 (range $9.81-$10.34) and revenue estimates of $3.284 billion (range $3.231-$3.365 billion) imply modest growth expectations, and the bullish tilt is notable given the stock's 11.2% one-year decline.

The target range is wide—$165.00 to $280.00, a spread of $115 or roughly 66% of the current price—which signals genuine disagreement about the company's trajectory. The high target of $280.00 (about 61.5% above the current price) likely assumes multiple expansion back toward historical tower-REIT premiums, reaccelerating domestic leasing from 5G densification and new spectrum deployments, and successful deleveraging that lowers the cost of capital. The low target of $165.00 (about 4.8% below the current price) prices in continued revenue stagnation, margin pressure from rising interest costs, and a persistent discount for the negative-equity balance sheet. Recent institutional actions show stability rather than momentum—Truist, Citigroup, and TD Cowen reiterated Buy in early November 2026, JP Morgan and Bernstein stayed Neutral/Market Perform, and Barclays and Morgan Stanley maintained Overweight and Equal Weight respectively—with no upgrades or downgrades in the visible record, indicating the Street is holding its positions while waiting for evidence of a growth inflection.

Drowning in data?

Find the real signal!

Bulls vs Bears: SBAC Investment Factors

The bear case currently carries slightly stronger near-term evidence: revenue is contracting 2.51% year over year, the forward PE exceeds the trailing PE, and EV/EBITDA of 17.79x is above the tower-REIT norm while growth is flat. The bull case rests on cash generation and valuation—$1.045 billion of TTM free cash flow, a 66.0% EBITDA margin, a PE compressed to 19.68x from 72.9x in 2022, and a 28.2% gap to the $222.19 average analyst target with zero Sell ratings. The single most important tension is whether domestic site leasing can reaccelerate from its $454.4 million plateau; if it does, the de-rated multiple re-rates toward historical tower premiums, but if carrier capex discipline persists, the stock remains a yield-and-buyback story with limited upside. Balance-sheet leverage—interest consuming 36% of operating income—is the swing factor that determines how much of the free cash flow reaches equity holders.

Bullish

  • Analyst targets imply 28% upside: The 21-analyst consensus is 'buy' with a recommendation mean of 2.18 and an average target of $222.19, roughly 28.2% above the $173.33 current price. The complete absence of Sell ratings (11 Buy, 11 Hold, 0 Sell) suggests the Street views the 11.2% one-year decline as overdone rather than structural.
  • Cash flow funds buybacks and deleveraging: Trailing-twelve-month free cash flow of $1.045 billion comfortably covers the $131.3 million quarterly dividend (45.5% payout ratio) while funding $300 million of Q3 2026 buybacks and $142.6 million of debt repayment. The 2.31% dividend yield and 16.06x P/FCF look undemanding for a business generating a 66.0% EBITDA margin.
  • Deep multiple compression near historical lows: The trailing PE has fallen from 72.9x in Q4 2022 and 62.8x in Q4 2023 to 19.68x today, with PS down from 44.4x to 7.37x. The PEG ratio of 0.477 and PE near the low end of its multi-year band suggest much of the de-rating is already priced in.
  • High-margin, contract-backed tower model: Q3 2026 gross margin of 75.97%, operating margin of 51.5%, and EBITDA margin of 66.0% reflect the durability of long-term lease escalators on roughly 46,000 towers. Domestic site leasing of $454.4 million remains a stable profit engine even as headline revenue dipped 2.51% year over year.

Bearish

  • Revenue is contracting, not growing: Q3 2026 revenue of $713.9 million fell 2.51% year over year from $732.3 million, and the last three quarters have been essentially flat at $703.4M, $715.3M, and $713.9M. For a tower REIT whose valuation hinges on organic leasing growth, a plateau in domestic site leasing ($454.4 million) undermines the core growth thesis.
  • Interest expense consumes 36% of operating income: Q3 2026 interest expense of $132.4 million absorbed roughly 36% of the $367.7 million in operating income, and the current ratio of 0.49 leaves thin near-term liquidity. With negative book equity (P/B of -4.27) and a distorted debt-to-equity of -3.16, the balance sheet offers little cushion if refinancing costs stay elevated.
  • Forward PE exceeds trailing PE: The forward PE of 21.88x is higher than the trailing 19.68x, an inversion implying the market expects earnings to decline or that trailing results were flattered by one-offs. Consensus EPS of $10.02 on revenue of $3.284 billion implies only modest growth against a flat top line.
  • Valuation rich on sales and EBITDA: EV/Sales of 11.58x and EV/EBITDA of 17.79x sit above the roughly 14-16x range typical for large-cap tower REITs, while PS of 7.37x is elevated for a REIT with declining revenue. The premium for asset quality is hard to justify while organic growth is stagnant.

SBAC Technical Analysis

SBAC is in a sustained, multi-quarter downtrend that has only recently begun to stabilize. The stock is down 11.23% over the past year and 9.95% year to date, and at $173.33 it sits at roughly 24.6% of its 52-week range of $156.60 to $224.46—squarely in the lower quartile of that band. That positioning signals a stock that has been persistently sold rather than one enjoying momentum; the 29.38% maximum drawdown confirms a deep correction, and the price remains about 22.8% below its 52-week high, meaning any rally so far has been a bounce within a larger downtrend rather than a confirmed reversal. Notably, the stock has outperformed a weak tape—relative strength versus SPY is +9.66% over one month and +4.84% over three months—so the absolute decline partly reflects broad market weakness (SPY -9.71% over one month) rather than purely idiosyncratic deterioration.

Short-term momentum is mixed but improving at the margin. The 1-month change of -4.61% and 3-month change of -5.07% are both better than the 6-month decline of -15.68%, indicating the pace of selling has decelerated and the stock is attempting to base. The most recent session was strong—a 2.16% gain to $173.33 from a $169.66 previous close on volume of roughly 855,000 shares—but that bounce follows a sharp mid-November slide from $189.35 on November 13 to $169.66 on November 19, a roughly 10% drop in four sessions that underscores how fragile the recovery attempt is. The 1-month trend no longer conflicts violently with the 1-year trend (both negative), which is more consistent with a maturing downtrend than a fresh breakdown, though the absence of RSI data limits confirmation of oversold conditions.

Key technical levels are well defined. Support rests at the 52-week low of $156.60, roughly 9.7% below the current $173.33; a breakdown there would signal capitulation and likely open a new leg lower, while the November 19 low near $169.66 is the first line of defense. Resistance sits at the 52-week high of $224.46, about 29.5% above the current price, with intermediate resistance around the $190-$195 area where the stock repeatedly failed in October and early November. With a beta of 0.968, SBAC is slightly less volatile than the market—about 3% less—which is unusual for a REIT with this much leverage and suggests the stock's risk is more balance-sheet and rate-driven than equity-beta-driven; position sizing should account for the elevated financial leverage even though market beta looks benign.

Beta

0.97

0.97x market volatility

Max Drawdown

-29.4%

Largest decline past year

52-Week Range

$157-$224

Price range past year

Annual Return

-11.2%

Cumulative gain past year

PeriodSBAC ReturnS&P 500
1m-0.0%-9.2%
3m-5.1%-9.7%
6m-15.7%-8.1%
1y-11.2%+4.7%
ytd-9.9%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

SBAC Fundamental Analysis

Revenue is contracting modestly and the trajectory is one of stabilization rather than growth. Q3 2026 revenue of $713.9 million fell 2.51% year over year versus $732.3 million in Q3 2025, extending a pattern of roughly flat-to-down top line: Q2 2026 came in at $715.3 million (up from $699.0 million a year earlier), Q1 2026 at $703.4 million (up from $664.2 million), and Q4 2025 at $719.6 million. The sequential trend is essentially flat—$703.4M, $715.3M, $713.9M across the last three quarters—indicating the company is neither accelerating nor collapsing but grinding along a plateau. Segment data shows domestic site leasing at $454.4 million and international site leasing at $211.0 million, with site development construction a small $48.6 million contributor; the domestic leasing base is the profit engine, and its stagnation is the core issue for the investment case, since tower REIT valuations hinge on organic leasing growth and escalator-driven revenue per site.

Profitability remains robust at the operating line even as reported net income is noisy. Q3 2026 gross margin was 75.97% (gross profit of $542.4 million on $713.9 million of revenue), operating margin was 51.5% ($367.7 million of operating income), and EBITDA was $471.4 million for a 66.0% EBITDA margin—figures that are consistent with the high-margin tower model and roughly in line with the 74.1%-77.1% gross margins reported across the prior four quarters. Net income of $231.3 million in Q3 2026 (a 32.4% net margin) was up from $198.8 million in Q2 2026 and $184.8 million in Q1 2026, though the quarterly figures are distorted by interest expense of $132.4 million and non-cash items. The headline metrics look contradictory—net margin of 37.4% and operating margin of 48.7% alongside a negative ROE of -21.7%—but the negative ROE and negative book value (P/B of -4.27) reflect an accumulated deficit from years of distributions and impairments rather than operating weakness; on a cash-flow basis the business is solidly profitable.

Balance sheet leverage is the central financial risk. The debt-to-equity ratio of -3.16 is an artifact of negative equity, but the underlying debt load is real: interest expense of $132.4 million in Q3 2026 consumed roughly 36% of operating income, and the current ratio of 0.49 signals thin near-term liquidity that is typical for a REIT but leaves little cushion. Free cash flow remains the saving grace—$1.045 billion on a trailing-twelve-month basis, with quarterly FCF of $252.3 million in Q3 2026, $344.8 million in Q2, and $206.7 million in Q1—funding $131.3 million of quarterly dividends and heavy buybacks ($300.0 million repurchased in Q3) while still allowing debt repayment of $142.6 million. The dividend payout ratio of 45.5% and 2.31% yield look sustainable against FCF, and the P/FCF ratio of 16.06 is undemanding for a business with 66% EBITDA margins; the question is whether FCF can keep growing if leasing revenue stays flat while refinancing costs remain elevated.

Quarterly Revenue

$713924000.0B

2026-09

Revenue YoY Growth

-2.5%

YoY Comparison

Gross Margin

76.0%

Latest Quarter

Free Cash Flow

$1.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Domestic Site Leasing Revenue
International Site Leasing Revenue
Site Development Construction

Open an Account, get $2 TSLA now!

Valuation Analysis: Is SBAC Overvalued?

Because net income is positive ($231.3 million in Q3 2026, EPS of $0.05 on a trailing basis but $2.19 diluted in the quarter), the PE ratio is the appropriate primary metric, and it tells a nuanced story. The trailing PE of 19.68x compares with a forward PE of 21.88x—an unusual inversion in which the forward multiple exceeds the trailing multiple, implying the market expects earnings to decline or that the trailing figure is flattered by one-off items. That gap is a warning sign: investors are not paying up for growth, and the PEG ratio of 0.477 (well below 1.0) suggests the stock is cheap relative to its earnings growth rate, though the reliability of that growth estimate is questionable given the flat revenue trajectory.

On peer and sector comparisons, SBAC screens cheap on earnings but expensive on sales and EBITDA. The PS ratio of 7.37x and EV/Sales of 11.58x are rich for a REIT with declining revenue, while EV/EBITDA of 17.79x is elevated relative to the roughly 14-16x range typical for large-cap tower REITs, reflecting the market's premium for asset quality and contract durability. The P/CF of 16.06x and dividend yield of 2.31% are more in line with REIT norms. The negative P/B of -4.27 is not meaningful given negative book equity, and the negative debt-to-equity ratio similarly distorts leverage comparisons; investors should focus on EV/EBITDA and P/FCF, where SBAC trades at a modest premium to its own history but a discount to its growth-era multiples.

Historical context is instructive: SBAC's PE ratio has compressed dramatically from 62.8x in Q4 2023 and 72.9x in Q4 2022 to 19.68x today, and its PS ratio has fallen from 44.4x in Q4 2022 to 7.37x now—a massive de-rating that reflects both earnings growth and multiple compression as the tower growth story matured. The current PE sits near the low end of its multi-year band, which could signal a value opportunity if earnings stabilize, but the falling multiple also reflects legitimate concerns about flat leasing revenue and high leverage. The market is no longer paying a growth premium for SBAC, and the stock's re-rating depends on evidence of reaccelerating organic growth or a more aggressive capital return program.

PE

19.7x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 14x~78x

vs. Industry Avg

41.5x

Industry PE ~41.5x*

EV/EBITDA

17.8x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on leverage and a stagnant top line. Q3 2026 interest expense of $132.4 million consumed roughly 36% of the $367.7 million in operating income, and the current ratio of 0.49 leaves minimal near-term liquidity cushion. Revenue fell 2.51% year over year to $713.9 million, with domestic site leasing flat at $454.4 million, so the company depends on cost discipline and buybacks rather than organic growth to move per-share metrics. Negative book equity (P/B of -4.27) and a distorted debt-to-equity of -3.16 mean traditional leverage ratios are uninformative, forcing investors to underwrite EV/EBITDA of 17.79x against a business whose revenue is not growing.

Market and competitive risks stem from valuation and carrier concentration. EV/Sales of 11.58x and EV/EBITDA of 17.79x sit above the roughly 14-16x typical for large-cap tower REITs, leaving room for multiple compression if growth does not inflect. Revenue is concentrated in the top three or four carriers in each market, so a single carrier's capex cut or consolidation (echoing the Sprint churn anniversary dynamics) can move results materially. With a beta of 0.968, SBAC is only slightly less volatile than the market, but its real sensitivity is to interest rates through refinancing costs rather than equity beta; the 29.38% maximum drawdown and -15.90% one-year relative strength versus SPY show how quickly sentiment can deteriorate when the growth narrative fades.

The worst-case scenario is a prolonged carrier capex freeze combined with elevated refinancing costs: domestic leasing stays flat, interest expense keeps consuming over a third of operating income, and the market applies a discount for negative equity. In that chain, the stock retests its 52-week low of $156.60, about 9.7% below the current $173.33, and a break there could open a new leg toward the $165 analyst low (roughly -4.8%) or lower on capitulation. A realistic adverse outcome is a decline of roughly 10% to the 52-week low, with a deeper drawdown toward the 29.38% maximum-drawdown magnitude (implying roughly $122) if a carrier contract loss coincides with a rate shock.

FAQ

The most severe risk is financial leverage: Q3 2026 interest expense of $132.4 million consumed about 36% of $367.7 million of operating income, and the current ratio of 0.49 leaves minimal liquidity cushion, so a rise in refinancing costs directly erodes the $1.045 billion free cash flow that supports the dividend and buyback. Second is revenue concentration and stagnation: domestic site leasing is flat at $454.4 million and total revenue fell 2.51% year over year, with the top three or four carriers in each market driving the bulk of leasing, so a single carrier capex cut or consolidation event can move results materially. Third is valuation compression: EV/EBITDA of 17.79x sits above the 14-16x tower norm, and a re-rating toward peer levels would pressure the shares even if operations hold steady. Fourth is the technical downtrend itself — the stock is 22.8% below its 52-week high with a 29.38% maximum drawdown, and a break below the $156.60 low could trigger further selling toward the $165 analyst low or lower. Ranked by severity, leverage and carrier concentration are the structural risks, while multiple compression and technical breakdown are the nearer-term price risks.

The 12-month forecast splits into three scenarios. The base case carries 50% probability with a $173.33-$222.19 range, assuming domestic site leasing stays near $454.4 million per quarter, interest expense holds near $132.4 million, and free cash flow remains above $1 billion to cover the 45.5% payout ratio. The bull case at 25% probability targets $222.19-$280.00, requiring domestic leasing to return to positive year-over-year growth on 5G densification and spectrum deployments, lifting EBITDA margin above 66.0% and driving multiple expansion toward the $280 high target. The bear case at 25% probability targets $156.60-$165.00, driven by a prolonged carrier capex freeze, further domestic leasing decline, and refinancing costs pushing interest expense above 36% of operating income. The base case is most likely because it requires only that current trends persist, and the key assumption behind it is that no top-three carrier cuts capex or consolidates. The wide $165-$280 analyst target spread, roughly 66% of the current price, reflects genuine disagreement about which scenario prevails.

The answer depends on the metric, which is why the stock is genuinely contested. On trailing earnings SBAC looks modestly undervalued: the 19.68x PE sits near the low end of its multi-year band after compressing from 62.8x in Q4 2023 and 72.9x in Q4 2022, and the 0.477 PEG is well below 1.0. On sales and EBITDA it looks expensive: PS of 7.37x and EV/Sales of 11.58x are rich for a REIT with declining revenue, and EV/EBITDA of 17.79x exceeds the roughly 14-16x typical for large-cap tower REITs. The forward PE of 21.88x exceeding the trailing 19.68x is a warning that consensus expects earnings to soften, which undercuts the cheap-earnings argument. The market appears to be pricing SBAC as a stable but low-growth cash-flow asset — paying for asset quality and contract durability while refusing to pay a growth premium. Fair value is therefore best described as roughly in line with the current price, with upside contingent on either domestic leasing growth returning or the EV/EBITDA multiple compressing toward peer norms.

From a risk/reward standpoint, SBAC offers roughly 28.2% upside to the $222.19 average analyst target against about 9.7% downside to the $156.60 52-week low, a ratio that is attractive on paper but conditional on a growth inflection that has not yet appeared. The 11 Buy / 11 Hold / 0 Sell consensus and 2.18 recommendation mean show the Street sees value, and the 19.68x trailing PE with a 0.477 PEG suggests the de-rating from 72.9x in Q4 2022 has gone far. The offsetting risk is that revenue is contracting 2.51% year over year and EV/EBITDA of 17.79x remains above the 14-16x tower-REIT norm, so the stock is not cheap on the metric that matters most for asset-heavy REITs. It is a reasonable buy for income and value investors who can wait for domestic leasing to reaccelerate and who value the 2.31% yield plus $300 million-per-quarter buyback, but it is a poor fit for anyone needing near-term price momentum given the -11.23% one-year return and -15.90% relative strength versus SPY. A staged entry near the $156.60-$165 support zone would improve the risk/reward materially versus buying at $173.33.

SBAC is better suited to long-term holding than short-term trading. The business is a mature, contract-backed tower REIT with roughly 46,000 sites, long-term lease escalators, and a 66.0% EBITDA margin, which gives it predictable cash flows but limited near-term catalysts — the growth inflection depends on carrier capex cycles that play out over multiple quarters. Its beta of 0.968 is only slightly below the market, but the real risk is balance-sheet and rate-driven rather than equity-beta-driven, and the 29.38% maximum drawdown shows how sharply sentiment can swing when the growth narrative fades. The 2.31% dividend yield and 45.5% payout ratio reward patience, and the $300 million-per-quarter buyback compounds per-share value while the share count shrinks from 105.4 million. A minimum holding period of two to three years is appropriate to allow domestic leasing to reaccelerate and for deleveraging to lower interest expense as a share of operating income. Short-term traders should note the stock is in a downtrend at 24.6% of its 52-week range, with support at $156.60 and resistance at $190-$195, and would need a confirmed break above that resistance before treating it as a momentum trade.